Racial Disparities in Receipt of Secondary Stroke Prevention Agents Among US Nursing Home Residents

Stroke

Volumn 34, Issue 11, 2003, Pages 2693-2697

  Christian, Jennifer B ^a   Lapane, Kate L ^a   Toppa, Rebecca S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Anticoagulants; Antiplatelet agents; Cerebrovascular accident; Ethnology; Nursing homes

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

AGED; ALZHEIMER DISEASE; AMERICAN INDIAN; ANTICOAGULANT THERAPY; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PEPTIC ULCER; PRIORITY JOURNAL; RACE DIFFERENCE; RECURRENT DISEASE; SECONDARY PREVENTION; STROKE; UNITED STATES;

AGED; ANTICOAGULANTS; ASPIRIN; CEREBROVASCULAR ACCIDENT; CONTINENTAL POPULATION GROUPS; DATABASES, FACTUAL; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; HEALTH SERVICES ACCESSIBILITY; HUMANS; NURSING HOMES; PREJUDICE; PREVENTIVE MEDICINE; RECURRENCE; RISK REDUCTION BEHAVIOR; TICLOPIDINE; UNITED STATES; WARFARIN;

EID: 0242525251     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000096993.90248.27     Document Type: Article

References (32)

1. Bornstein NM, Korczyn AD. Prevention of recurrent stroke. In: Norris JW, Hachinski VC, eds. Prevention of Stroke. New York, NY: Springer-Verlag; 1991:261-268.
2. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke: EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993;342:1255-1262.
3. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients: Antiplatelet Trialists' Collaboration. BMJ. 1994;308:81-106.
4. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259-268.
5. Gorelick PB. Cerebrovascular disease in African Americans. Stroke. 1998;29:2656-2664.
6. Gould SJ. Ghosts of bell curves past: the mismeasure of man continues, as a current bestseller revives academic racism's old arguments. Nat Hist. 1995;104:12-19.
7. Quilliam BJ, Lapane KL. Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke. 2001;32:1385-1393.
8. Leibson CL, Ransom JE, Brown RD, O'Fallon WM, Hass SL, Whisnant JP. Stroke-attributable nursing home use: a population-based study. Neurology. 1998;51;163-168.
9. Gambassi G, Landi F, Peng L, Brostrup-Jensen C, Calore K, Hiris J, Lipsitz L, Mor V, Bernabei R. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group: Systematic Assessment of Geriatric Drug Use Via Epidemiology. Med Care. 1998;36:167-179.
10. Bernabei R, Gambassi G, Lapane K, Sgadari A, Landi F, Gatsonis C, Lipsitz L, Mor V. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care: SAGE (Systematic Assessment of Geriatric Drug Use Via Epidemiology) Study Group. J Gerontol A Biol Sci Med Sci. 1999;54:M25-M33.
11. Minimum Data Set Plus Training Manual. Natick, Mass: Eliot Press; 1991.
12. Morris JN, Hawes C, Fries BE, Phillips CD, Mor V, Katz S, Murphy K, Drugovich ML, Friedlob AS. Designing the national resident assessment instrument for nursing homes. Gerontologist. 1990;30:293-307.
13. Phillips CD, Morris JN, Hawes C, Fries BE, Mor V, Nennstiel M, Iannacchione V. Association of the resident assessment instrument (RAI) with changes in function, cognition, and psychosocial status. J Am Geriatr Soc. 1997;45:986-993.
14. Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, Lipsitz LA. MDS cognitive performance scale. J Gerontol. 1994;49:M174-M182.
15. Frederiksen K, Tariot P, De Jonghe E. Minimum data set plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc. 1996;44:305-309.
16. Benesch C, Witter DM Jr, Wilder AL, Duncan PW, Samsa GP, Matchar DB. Inaccuracy of the international classification of diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology. 1997;49:660-664.
17. Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29:1602-1604.
18. Leibson CL, Naessens JM, Brown RD, Whisnant JP. Accuracy of hospital discharge abstracts for identifying stroke. Stroke. 1994;25:2348-2355.
19. Hartmaier SL, Sloane PD, Guess HA, Koch GG. The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set. J Am Geriatr Soc. 1994;42:1173-1179.
20. Mendelson G, Aronow WS. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc. 1998;46:1423-1424.
21. Stafford RS, Singer DE. Recent national pattems of warfarin use in atrial fibrillation. Circulation. 1998;97:1231-1233.
22. Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc. 1997;45:1060-1065.
23. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med. 1997;157:978-984.
24. Quilliam BJ, Lapane KL, Eaton CB, Mor V. Effect of antiplatelet and anticoagulant agents on rates of all-cause mortality among elderly nursing home residents with recent ischemic stroke. In: Research to Action: Shaping Our Health Care Future. Washington, DC: Academy Health; 2001:45.
25. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641-1647.
26. Lee YP, Schommer JC. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions. Am J Health Syst Pharm. 1996;53:1580-1583.
27. Gurwitz JH. Improving safety of anticoagulation in the nursing home. Grant No. 1POIHS011534, 2001-2006.
28. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2001;119:300-320S.
29. Lapane KL, Spooner JJ, Mucha L, Straus WL. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc. 2001;49:577-584.
30. Quilliam BJ, Lapane KL, Eaton CB, Mor V. Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors. Stroke. 2001;32:2299-2304.
31. Broderick J, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992;326:733-736.
32. Mitchell JB, Ballard DJ, Matchar DB, Whisnant JP, Samsa GP. Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. Health Serv Res. 2000;34:1413-1428.